"rofecoxib" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "rofe-",
        "3": "-coxib",
        "qq1": "of unknown origin",
        "t2": "selective cyclo-oxygenase inhibitor"
      },
      "expansion": "rofe- (of unknown origin) + -coxib (“selective cyclo-oxygenase inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From rofe- (of unknown origin) + -coxib (“selective cyclo-oxygenase inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "rofecoxib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with rofe-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -coxib",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Healthcare",
            "Fundamental",
            "Health",
            "Body"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A COX-2 inhibitor C₁₇H₁₄O₄S (trademark Vioxx) used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis, to manage acute pain in adults, and to treat primary dysmenorrhea but withdrawn from sale by the manufacturer because of its link to cardiovascular events (as heart attack and stroke)."
      ],
      "id": "en-rofecoxib-en-noun-v8zvV-OC",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "Vioxx",
          "Vioxx"
        ],
        [
          "osteoarthritis",
          "osteoarthritis"
        ],
        [
          "rheumatoid arthritis",
          "rheumatoid arthritis"
        ],
        [
          "pain",
          "pain"
        ],
        [
          "primary",
          "primary"
        ],
        [
          "dysmenorrhea",
          "dysmenorrhea"
        ],
        [
          "cardiovascular",
          "cardiovascular"
        ],
        [
          "heart attack",
          "heart attack"
        ],
        [
          "stroke",
          "stroke"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A COX-2 inhibitor C₁₇H₁₄O₄S (trademark Vioxx) used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis, to manage acute pain in adults, and to treat primary dysmenorrhea but withdrawn from sale by the manufacturer because of its link to cardiovascular events (as heart attack and stroke)."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "rofecoxib"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌɹoʊ.fəˈkɑk.sɪb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "rofecoxib"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "rofe-",
        "3": "-coxib",
        "qq1": "of unknown origin",
        "t2": "selective cyclo-oxygenase inhibitor"
      },
      "expansion": "rofe- (of unknown origin) + -coxib (“selective cyclo-oxygenase inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From rofe- (of unknown origin) + -coxib (“selective cyclo-oxygenase inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "rofecoxib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms prefixed with rofe-",
        "English terms suffixed with -coxib",
        "English uncountable nouns",
        "Pages with 1 entry",
        "Pages with entries",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A COX-2 inhibitor C₁₇H₁₄O₄S (trademark Vioxx) used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis, to manage acute pain in adults, and to treat primary dysmenorrhea but withdrawn from sale by the manufacturer because of its link to cardiovascular events (as heart attack and stroke)."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "Vioxx",
          "Vioxx"
        ],
        [
          "osteoarthritis",
          "osteoarthritis"
        ],
        [
          "rheumatoid arthritis",
          "rheumatoid arthritis"
        ],
        [
          "pain",
          "pain"
        ],
        [
          "primary",
          "primary"
        ],
        [
          "dysmenorrhea",
          "dysmenorrhea"
        ],
        [
          "cardiovascular",
          "cardiovascular"
        ],
        [
          "heart attack",
          "heart attack"
        ],
        [
          "stroke",
          "stroke"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A COX-2 inhibitor C₁₇H₁₄O₄S (trademark Vioxx) used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis, to manage acute pain in adults, and to treat primary dysmenorrhea but withdrawn from sale by the manufacturer because of its link to cardiovascular events (as heart attack and stroke)."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "rofecoxib"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌɹoʊ.fəˈkɑk.sɪb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "rofecoxib"
}